External organizationBristol-Myers Squibb Belgium SA (BMS)

Basic data

Name:

Bristol-Myers Squibb Belgium SA

Acronym:

BMS

Country:

Belgium

City:

Brüssel

URL:

https://www.bms.com/

Projects

CA209-76K: Efficacy Study of Nivolumab Compared to Placebo in Prevention of Recurrence of MelanomaAfter Complete Resection of Stage IIB/C Melanoma (CheckMate 76K)

2020 - 2027

Bristol-Myers Squibb Belgium SA (BMS)

2018 - 2021

Bristol-Myers Squibb Belgium SA (BMS)

Studie CA209-511 (EUDRACT Number 2015-004920-67)

2016 - 2022

Bristol-Myers Squibb Belgium SA (BMS)

Help

will be deleted permanently. This cannot be undone.